You searched for: Medicine and Biomedical Sciences
1 to 3 of 3 results
Show
results per page
Matched phrases in profile:
in Medicine (2022) 24(2) (398–409), (S109836002105348X), (10.1016/j.gim.2021.09.020))… We and our international Endometrial Cancer Association Consortium collaborators have identified… After completing his BSc and MSc (Hons) at the University of Canterbury (NZ), Dylan worked for… performed comprehensive fine-mapping analyses of 3633 genotyped and imputed single nucleotide…
After completing his BSc and MSc (Hons) at the University of Canterbury (NZ), Dylan worked for five years as a Research Scientist at Antisoma Research Limited (London, UK), developing antibody-enzyme fusion proteins for cancer therapy. He returned to New Zealand to carry out his PhD research into an …
Large numbers of germline genetic variants have been found to associate with disease. A major roadblock in our understanding of how genetics contribute to disease has been a lack of knowledge of the molecular effects of variants. Thus, the aim of my research program is to use genetic analyses to ass …
Matched phrases in profile:
, dementia, epilepsy, persistent pain) and enhancing affective-cognitive Resilience in Contested… Precision switch medicine: transdiagnostic stratification of bipolar and related disorders with an integrated phenotyping and genetics analysis cloud platform… , physics, computer science, mathematics & statistics, biological/life sciences, medicine & allied… & resilience with the following projects: [1] Precision Pain Medicine… implications for biologically based nosology frameworks in pain medicine and psychiatry.…
I completed a PhD in Neuroscience with Jack Pettigrew (FRS) at Vision, Touch & Hearing Research Centre followed by an NHMRC Clinical Research Fellowship at Alfred Health & Monash University.
Back in QLD I'm continuing a transdisciplinary research & innovation program to Bring Discoveries of the Bra …
Matched phrases in profile:
Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation… increases, these approaches can be used to inform treatment strategies and personalised medicine.… Prof David Ascher is currently an NHMRC Investigator and Director of the Biotechnology Program… personalized medicine, their development and optimization has been largely through experimental exploration…
Prof David Ascher is currently an NHMRC Investigator and Director of the Biotechnology Program at the University of Queensland. He is also Head of Computational Biology and Clinical Informatics at the Baker Institute.
David’s research focus is in modelling biological data to gain insight into fun …
We have successfully translated our computational tools into the clinic and industry, including:
1 to 3 of 3 results